Cellecta Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$528K
- Investors
-
1
Cellecta General Information
Description
Provider of genomics products and services intended to develop advanced high-throughput RNAi and peptide screen technologies. The company focuses on RNAi and CRISPR technologies for the discovery and characterization of novel therapeutic targets and genetic profiling for biomarker discovery, thereby providing HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets.
Contact Information
Website
www.cellecta.comCorporate Office
- 320 Logue Avenue
- Mountain View, CA 94043
- United States
Corporate Office
- 320 Logue Avenue
- Mountain View, CA 94043
- United States
Cellecta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Debt - PPP | 01-May-2020 | $528K | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2017 | Completed | Startup |
Cellecta Comparisons
Industry
Financing
Details
Cellecta Competitors (48)
One of Cellecta’s 48 competitors is PhenoVista, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PhenoVista | Formerly VC-backed | San Diego, CA | ||||
| Horizon Discovery | Formerly VC-backed | Cambridge, United Kingdom | ||||
| ABM (Canada) | Corporation | Richmond, Canada | ||||
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| CYTOO | Venture Capital-Backed | Grenoble, France |
Cellecta Patents
Cellecta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026169400-A1 | Methods, kits and compositions for multiplex preparation of nucleic acids for next generation sequencing | Pending | 10-Feb-2025 | ||
| CA-3153296-A1 | Single cell genetic analysis | Pending | 24-Mar-2020 | ||
| EP-4127221-A1 | Single cell genetic analysis | Inactive | 24-Mar-2020 | ||
| EP-4127221-A4 | Single cell genetic analysis | Inactive | 24-Mar-2020 | ||
| US-20210301329-A1 | Single cell genetic analysis | Inactive | 24-Mar-2020 | C12Q1/6806 |
Cellecta Signals
Cellecta Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government |
Cellecta FAQs
-
When was Cellecta founded?
Cellecta was founded in 2006.
-
Where is Cellecta headquartered?
Cellecta is headquartered in Mountain View, CA.
-
What is the size of Cellecta?
Cellecta has 27 total employees.
-
What industry is Cellecta in?
Cellecta’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Cellecta a private or public company?
Cellecta is a Private company.
-
What is Cellecta’s current revenue?
The current revenue for Cellecta is .
-
Who are Cellecta’s investors?
U.S. Department of Health and Human Services has invested in Cellecta.
-
Who are Cellecta’s competitors?
PhenoVista, Horizon Discovery, ABM (Canada), CIS Bio International, and CYTOO are some of the 48 competitors of Cellecta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process